Tianjin Pharmaceutical Group Co., Ltd., a state-owned pharmaceutical group with chemical and biological pharmaceuticals, green traditional Chinese medicine, and high-end medical devices as the main body, owns time-honored brands such as Darentang and Longshunrong, as well as famous brands such as Shuangyan and Songbai
Tianjin Pharmaceutical Group is a large-scale state-owned comprehensive pharmaceutical group, with chemical and biopharmaceutical, green traditional Chinese medicine, high-end medical equipment, and modern commercial logistics as the main body, with integrated operation of scientific research, production and commercial sales, with more than 100 holding or shareholding enterprises, as well as three listed companies, Zhongxin Pharmaceutical, Tianyao Co., Ltd., and Lisheng Pharmaceutical, and has cooperated with a number of multinational pharmaceutical groups to form more than 10 joint ventures.
The group is rich in product resources, with more than 1,300 kinds of products in production, covering traditional Chinese medicine, chemical drugs, biological vaccines, medical devices and other categories, the production capacity of corticosteroid raw materials ranks among the top in the world, the production and sales of medicinal amino acid raw materials are in the forefront of China, and a large number of "big varieties" that enjoy wide popularity and reputation such as fast-acting Xingxin pills, Shoubishan, Jingwanhong ointment, Tongmai Yangxin pills, and You Zhuoer are sold at home and abroad. Four traditional production techniques, such as Darentang, Qinggong Shou Taomaru, were included in the national intangible cultural heritage list.
The group implements innovation-driven, adheres to the R&D ideas of independent innovation, introduction, digestion and absorption, and the combination of production, education and research, and has formed a scientific and technological innovation system composed of 1 national drug research and development institution - Tianjin Pharmaceutical Research Institute, 2 national enterprise technology centers and 18 municipal enterprise technology centers, cultivated a scientific and technological research and development team led by academicians of the Academy of Engineering, complete leaders of various disciplines and high-quality talents, and built a scientific and technological innovation echelon development pattern of development generation, production generation, reserve generation and pre-research generation. The scientific research strength continues to increase, and it has won the first and second prizes of the National Science and Technology Progress Award, the China Patent Excellence Award, and many of its enterprises have been recognized as national innovative enterprises and national technological innovation demonstration enterprises.
Stand at a new starting point and achieve a new leap. Tianjin Pharmaceutical Group will continue to aim at the international advanced level, adhere to the guidance of science and technology, focus on the implementation of large varieties and capital operation strategies, and strive to build the most innovative and competitive new leading enterprises in China's pharmaceutical industry, and make greater contributions to the cause of human health.
